CLINICAL CHARACTERISTICS AND FIB-4 RISK STRATIFICATION OF PRIMARY CARE PATIENTS WITH OBESITY, DIABETES, OR BOTH: REAL-WORLD IMPLICATIONS FOR ADOPTING A FIB-4 REFERRAL ALGORITHM TO DETECT METABOLIC DYSFUNCTION-ASSOCIATION STEATOTIC LIVER DISEASE (MASLD) WITH ADVANCED FIBROSIS

被引：0

作者：

Chu, Janet ^{[1
]}

Khalili, Mandana ^{[1
]}

Goldman, Max ^{[2
]}

Hameed, Bilal ^{[1
]}

Ha, Nghiem ^{[1
]}

Fox, Rena ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] Kaiser Permanente San Francisco Med Ctr, San Francisco, CA USA

来源：

HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1141

引用

页码：S868 / S869

页数：2

共 24 条

[11] Limited Success of Point-of-Care Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Related Fibrosis Using FIB-4/Transient Elastography in a Weight Management/Diabetes Clinic
Townsend, Clare
Rizo, Ivania
Fantasia, Kathryn
Mohanty, Arpan
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1269 - S1269
[12] Accuracy of a sequential algorithm based on FIB-4 and ELF to identify high-risk advanced liver fibrosis at the primary care level
Gabriel-Medina, Pablo
Ferrer-Costa, Roser
Ciudin, Andreea
Augustin, Salvador
Rivera-Esteban, Jesus
Pericas, J. M.
Selva, D. M.
Rodriguez-Frias, Francisco
INTERNAL AND EMERGENCY MEDICINE, 2024, 19 (03) : 745 - 756
[13] Accuracy of a sequential algorithm based on FIB-4 and ELF to identify high-risk advanced liver fibrosis at the primary care level
Pablo Gabriel-Medina
Roser Ferrer-Costa
Andreea Ciudin
Salvador Augustin
Jesus Rivera-Esteban
J. M. Pericàs
D. M. Selva
Francisco Rodriguez-Frias
Internal and Emergency Medicine, 2024, 19 : 745 - 756
[14] Diagnostic performance of new BAST score versus FIB-4 index in predicating of the liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
Helal, Eman
Elgebaly, Fatma
Mousa, Nasser
Elbaz, Sherif
Abdelsalam, Mostafa
Abdelkader, Eman
El-Sehrawy, Amr
El-wakeel, Niveen
El-Emam, Ola
Hashem, Manal
Elmetwalli, Alaa
Mansour, Shimaa
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01)
[15] The use of ELF test, FIB-4 and sequential algorithms to screen the Type 2 Diabetes Mellitus (T2DM) population for advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Pei, Yiying
Sng, Wei Kwan
Quah, Joanne Hui Min
Liu, Jin
Chong, Bee Yen
Lee, Hwee Khim
Wang, Xue Fei
Tan, Ngiap Chuan
Chang, Jason Pik Eu
Tan, Hong Chang
Bee, Yong Mong
Goh, George Boon Bee
JOURNAL OF HEPATOLOGY, 2024, 80 : S525 - S525
[16] Association of FIB-4 score with disease progression in real-world populations diagnosed with NAFLD/NASH or at risk of NASH in US clinical practice
Lai, Michelle
Broestl, Jeremy
Frick, Andrew
Haubrich, Richard
Koch, Bruce
Milligan, Scott
Natha, Macky
Younossi, Zobair
Afdhal, Nezam
JOURNAL OF HEPATOLOGY, 2020, 73 : S159 - S159
[17] COMPARATIVE ANALYSIS OF TWO METHODS OF FIB-4 CALCULATION IN PRIMARY CARE TO IDENTIFY ADVANCED FIBROSIS IN PATIENTS WITH DIABETES: IMPLICATIONS FOR ADHERENCE TO THE AASLD MASH CARE PATHWAY
Mageras, Anna
Nathani, Rohit
DeBroff, Jake
Hussein, Rama
Anand, Rahul
Villarroel, Carolina
Yarra, Silpa
Mack, Theresa
Priven, Nina
Viola, Heather
Wang, Stephanie
Carnavali, Fernando
Bansal, Meena
HEPATOLOGY, 2024, 80
[18] Poor Performance of FIB-4 in Fibrosis Prediction for Chronic Hepatitis B Patients with Metabolic Dysfunction-Associated Liver Disease in Daily Clinical Practice
Abu Baker, Fadi
Abu Mouch, Saif
Nicola, Dorin
Taher, Randa
JOURNAL OF HEPATOLOGY, 2024, 80 : S789 - S789
[19] Real-world use of the FIB-4 calculator in primary care workflows to screen for advanced non-alcoholic fatty liver disease in a large US health system
Therapondos, George
Thomas, Anna
Dieterich, Douglas T.
Girgrah, Nigel
Oravetz, Philip
JOURNAL OF HEPATOLOGY, 2022, 77 : S432 - S432
[20] USE OF FIB-4 INDEX TO ASSESS RISK OF ADVANCED FIBROSIS: A RETROSPECTIVE COHORT STUDY OF PRIMARY CARE PATIENTS WITH DIABETES AT A LARGE, URBAN TEACHING HOSPITAL
Wen, Shawn
Northup, Patrick G.
Levy, Natalie
Liapakis, AnnMarie
GASTROENTEROLOGY, 2024, 166 (05) : S656 - S657

← 1 2 3 →